Alphabiome AI

Website: https://www.alphabiome.ai/

Alphabiome is pioneering a new approach to decoding the microbiome and predicting drug response using advanced AI. Our platform delivers proprietary, IP-protected biomarkers backed by robust human data, ready for direct licensing.

Founded by MIT AI experts and Stanford Nobel Laureates in genetics, the company has already discovered over 100,000 novel biomarkers. The technology has been validated in large-scale animal trials and shown proof-of-concept in humans, with recent breakthroughs in predicting drug efficacy for Crohn’s and Colitis.

Helix AI

Website: https://helixai.com/

HelixAI is a specialist scientific technology company focused on accelerating research and development for biopharmaceutical organizations. Its platform, JarvisAI, enables scientific teams to design and execute in silico R&D workflows that support a wide range of operations from early-stage drug discovery to scale-up and bioproduction. By integrating scientific data from public, private and client domains along with computational models and AI-driven orchestration, JarvisAI helps researchers explore hypotheses more efficiently and prioritize the most promising drug candidates for further development. This approach supports better, faster decision-making combined with optimization of scientific and wet-lab resources.